Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737665) titled 'Efficacy of Melatonin Treatment on Sleep Quality Improvement in Inflammatory Bowel Disease Patients With Clinical Remission: A Randomized Double-Blind Placebo-Controlled Trial' on July 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Mahidol University

Condition: IBD (Inflammatory Bowel Disease)

Intervention: Drug: Melatonin ("Circadin")

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: April 1, 2025 ...